ERLOTINIB



Erlocip


Indication:

It is used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).



Brand name: Erlocip

Active Ingeridents: Erlotinib

Company Name: Cipla

Package: 30 Tabs

Strength : 100mg

Mechanism of action:


Doxopar (Doxorubicin ) has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Doxopar (Doxorubicin ) forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.


Dosage and Administration:


Use Erlocip (Erlotinib) as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Erlocip (Erlotinib) by mouth with a glass of water on an empty stomach at least 1 hour before or 2 hours after eating.

  • Wash your hands immediately after taking Erlocip (Erlotinib) .

  • Take Erlocip (Erlotinib) on a regular schedule to get the most benefit from it. Taking Erlocip (Erlotinib) at the same time each day will help you to remember to take it.

  • If you miss a dose of Erlocip (Erlotinib) , contact your doctor right away.

Side effects:


Important things to remember about the side effects of Erlocip (Erlotinib) :


  • The following side effects are common (occurring in greater than 30%) for patients taking Erlocip (Erlotinib) :
  • Rash , Diarrhea, Poor appetite, Fatigue, Shortness of breath, Cough, Nausea and vomiting
  • These side effects are less common side effects (occurring in about 10-29%) of patients receiving Erlocip (Erlotinib) :
  • Infection, Mouth sores, Itching, Dry skin, Eye irritation, Abdominal pain

Store:


Erlocip (Erlotinib) room temperature away from moisture and heat.










Precaution:



Before starting Erlocip (Erlotinib) treatment, make sure you tell your doctor about any other medications you are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). Certain medications can interfere with the levels/effects of Erlocip (Erlotinib) . It is important your oncologist is aware of all medications. Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.


WARNING:


Erlocip is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



Erlocip



Indication:

It is used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).



Brand name: Erlocip

Active Ingeridents: Erlotinib

Company Name: Cipla

Package: 30 Tabs

Strength :150mg

Mechanism of action:


Erlocip (Erlotinib) is an epidermal growth factor receptor inhibitor (EGFR inhibitor). The drug follows gefitinib, which was the first drug of this type. Erlocip (Erlotinib) specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. When Erlocip (Erlotinib) binds to EGFR, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated.


Dosage and Administration:


Use Erlocip (Erlotinib) as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Erlocip (Erlotinib) by mouth with a glass of water on an empty stomach at least 1 hour before or 2 hours after eating.

  • Wash your hands immediately after taking Erlocip (Erlotinib) .

  • Take Erlocip (Erlotinib) on a regular schedule to get the most benefit from it. Taking Erlocip (Erlotinib) at the same time each day will help you to remember to take it.

  • If you miss a dose of Erlocip (Erlotinib) , contact your doctor right away.

Store:


Erlocip (Erlotinib) room temperature away from moisture and heat.


Side effects:


Important things to remember about the side effects of Erlocip (Erlotinib):


  • The following side effects are common (occurring in greater than 30%) for patients taking Erlocip (Erlotinib) :

  • Rash , Diarrhea, Poor appetite, Fatigue, Shortness of breath, Cough, Nausea and vomiting

  • These side effects are less common side effects (occurring in about 10-29%) of patients receiving Erlocip (Erlotinib) :

  • Infection, Mouth sores, Itching, Dry skin, Eye irritation, Abdominal pain

Precaution:


Before starting Erlocip (Erlotinib) treatment, make sure you tell your doctor about any other medications you are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). Certain medications can interfere with the levels/effects of Erlocip (Erlotinib) . It is important your oncologist is aware of all medications. Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.









WARNING:


Erlocip is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



Erlonat



Indication:

It is used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).



Brand name: Erlonat

Active Ingeridents: Erlotinib

Company Name: Natco

Package: 30 Tabs

Strength : 100mg

Mechanism of action:


Erlonat (Erlotinib) is an epidermal growth factor receptor inhibitor (EGFR inhibitor). The drug follows gefitinib, which was the first drug of this type. Erlonat (Erlotinib) specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. When Erlonat (Erlotinib) binds to EGFR, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated.


Dosage and Administration:


Use Erlonat (Erlotinib) as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Erlonat (Erlotinib) by mouth with a glass of water on an empty stomach at least 1 hour before or 2 hours after eating.

  • Wash your hands immediately after taking Erlonat (Erlotinib) .

  • Take Erlonat (Erlotinib) on a regular schedule to get the most benefit from it. Taking Erlonat (Erlotinib) at the same time each day will help you to remember to take it.

  • If you miss a dose of Erlonat (Erlotinib) , contact your doctor right away.

Store:


Erlonat (Erlotinib) room temperature away from moisture and heat.


Side effects:


Important things to remember about the side effects of Erlonat (Erlotinib) :


  • The following side effects are common (occurring in greater than 30%) for patients taking Erlonat (Erlotinib) :

  • Rash , Diarrhea, Poor appetite, Fatigue, Shortness of breath, Cough, Nausea and vomiting

  • These side effects are less common side effects (occurring in about 10-29%) of patients receiving Erlonat (Erlotinib) :

  • Infection, Mouth sores, Itching, Dry skin, Eye irritation, Abdominal pain

Precaution:


Before starting Erlonat (Erlotinib) treatment, make sure you tell your doctor about any other medications you are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). Certain medications can interfere with the levels/effects of Erlonat (Erlotinib) . It is important your oncologist is aware of all medications. Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.








WARNING:


Erlonat is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



Erlonat



Indication:

It is used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).



Brand name: Erlonat

Active Ingeridents: Erlotinib

Company Name: Natco

Package: 30 Tabs

Strength : 150mg

Mechanism of action:


Erlonat (Erlotinib) is an epidermal growth factor receptor inhibitor (EGFR inhibitor). The drug follows gefitinib, which was the first drug of this type. Erlonat (Erlotinib) specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. When Erlonat (Erlotinib) binds to EGFR, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated.


Dosage and Administration:


Use Erlonat (Erlotinib) as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Erlonat (Erlotinib) by mouth with a glass of water on an empty stomach at least 1 hour before or 2 hours after eating.

  • Wash your hands immediately after taking Erlonat (Erlotinib) .

  • Take Erlonat (Erlotinib) on a regular schedule to get the most benefit from it. Taking Erlonat (Erlotinib) at the same time each day will help you to remember to take it.

  • If you miss a dose of Erlonat (Erlotinib) , contact your doctor right away.

Side effects:


Important things to remember about the side effects of Erlonat (Erlotinib) :


  • The following side effects are common (occurring in greater than 30%) for patients taking Erlonat (Erlotinib) :

  • Rash , Diarrhea, Poor appetite, Fatigue, Shortness of breath, Cough, Nausea and vomiting

  • These side effects are less common side effects (occurring in about 10-29%) of patients receiving Erlonat (Erlotinib) :

  • Infection, Mouth sores, Itching, Dry skin, Eye irritation, Abdominal pain

Store:


Erlonat (Erlotinib) room temperature away from moisture and heat.


Precaution:


Before starting Erlonat (Erlotinib) treatment, make sure you tell your doctor about any other medications you are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). Certain medications can interfere with the levels/effects of Erlonat (Erlotinib) . It is important your oncologist is aware of all medications. Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.



WARNING:


Erlonat is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



Tarceva



Indication:

It is used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).



Brand name: Tarceva

Active Ingeridents: (Tarceva)Erlotinib

Company Name: Roche

Package: 10 Tabs in Strip

Strength : 150mg

Mechanism of action:


Tarceva (Erlotinib) is an epidermal growth factor receptor inhibitor (EGFR inhibitor). The drug follows gefitinib, which was the first drug of this type. Tarceva (Erlotinib) specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. When Tarceva (Erlotinib) binds to EGFR, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated.


Dosage and Administration:


Use Tarceva (Erlotinib) as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Tarceva (Erlotinib) by mouth with a glass of water on an empty stomach at least 1 hour before or 2 hours after eating.

  • Wash your hands immediately after taking Tarceva (Erlotinib) .

  • Take Tarceva (Erlotinib) on a regular schedule to get the most benefit from it. Taking Tarceva (Erlotinib) at the same time each day will help you to remember to take it.

  • If you miss a dose of Tarceva (Erlotinib) , contact your doctor right away.

Side effects:


Important things to remember about the side effects of Tarceva (Erlotinib) :


  • The following side effects are common (occurring in greater than 30%) for patients taking Tarceva (Erlotinib) :

  • Rash , Diarrhea, Poor appetite, Fatigue, Shortness of breath, Cough, Nausea and vomiting

  • These side effects are less common side effects (occurring in about 10-29%) of patients receiving Tarceva (Erlotinib) :

  • Infection, Mouth sores, Itching, Dry skin, Eye irritation, Abdominal pain

Store:


Tarceva (Erlotinib) room temperature away from moisture and heat.


Precaution:


Before starting Erlonat (Erlotinib) treatment, make sure you tell your doctor about any other medications you are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). Certain medications can interfere with the levels/effects of Erlonat (Erlotinib) . It is important your oncologist is aware of all medications. Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.



WARNING:


Tarceva is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.